PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808955
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808955
Cardiac Event Monitor Market size was valued at US$ 2,125.29 Million in 2024, expanding at a CAGR of 8.50% from 2025 to 2032.
The Cardiac Event Monitor Market is a subset of the medical device industry that focuses on the design, manufacture, and distribution of devices that continuously or intermittently monitor the electrical activity of the heart to detect irregularities such as arrhythmias. Wearable patches and portable monitors, as well as implantable loop recorders, are used in clinical and home settings to capture and transmit cardiac data over days, weeks, or months. The market promotes early diagnosis and management of heart conditions, which reduces hospital visits and improves patient outcomes. It includes hardware, software, and associated services for hospitals, diagnostic centers, and outpatient care facilities.
Cardiac Event Monitor Market- Market Dynamics
Enhanced healthcare infrastructure propels market growth
The Cardiac Event Monitor Market is expected to grow as healthcare infrastructure expands and improves. This infrastructure includes the physical facilities, personnel, and systems required for healthcare delivery. This infrastructure is critical to the development and effective use of cardiac event monitors, as it ensures access to advanced devices for preventing, diagnosing, and treating cardiovascular diseases. As healthcare spending increases, as it has in the United States, there is a greater investment in technologies such as cardiac event monitors. According to the National Health Expenditure Account (NHEA), published by the Centers for Medicare and Medicaid Services, a US-based federal agency, healthcare spending in the United States increased 2.7% in 2021, reaching $4.3 trillion, or $12,914 per person. Health spending represented 18.3% of the nation's GDP.
Cardiac Event Monitor Market- Key Insights
According to our research analyst's analysis, the global market is expected to grow at a compound annual growth rate (CAGR) of approximately 8.50% during the 2025-2032 forecast period.
Cardiovascular rhythm management devices were projected to have the largest market share in 2025 based on product segmentation.
The hospital was the top End-Use in 2025 according to End-Use segmentation.
In 2025, North America ranked as the top revenue-generating region.
The Global Cardiac Event Monitor Market is segmented on the basis of Product, End-Use, and Region.
Based on the product, the market is split into two categories: Cardiac Monitoring Devices, and Cardiac Rhythm Management Devices. Cardiovascular rhythm management devices are expected to have the highest market share in 2025. The high proportion is due to the introduction of technologically advanced cardiac rhythm management devices, such as smartwatches and fitness trackers, which can help with AFib detection and screening. Cardiac resynchronization therapy, defibrillators, and pacemakers are all subsets of the cardiac rhythm management devices segment.
Based on end-use, the market is separated into two categories: Home Healthcare, Hospitals, Ambulatory Centers, and Others. In 2025, the hospital segment will dominate the market. Hospitals provide the best care for CVD patients and enable early diagnosis, resulting in tremendous growth. According to the American Heart Association, 209,000 patients died as a result of in-hospital cardiac arrest in the United States in 2016, and this figure is expected to rise to more than 23.6 million by 2030. Because of its low cost and ease of treatment, the home health care segment is expected to be the fastest-growing sub-segment in the cardiac monitoring and cardiac rhythm management market during the forecast period.
Cardiac Event Monitor Market- Geographical Insights
North America is expected to dominate the Cardiac Event Monitor Market in 2025, owing to its advanced healthcare infrastructure, widespread adoption of innovative medical technologies, and high prevalence of cardiovascular diseases. The United States, in particular, dominates the market, investing heavily in cardiac monitoring device research and development (R&D). The region is also experiencing an aging population, which fuels demand for these devices. Additionally, remote patient monitoring is gaining traction, aided by favorable reimbursement policies and strict healthcare regulations. These factors combine to significantly contribute to the growth of the North American cardiac monitoring device market.
The Asia-Pacific (APAC) region is the fastest-growing market for Cardiac Event Monitor. The large and aging population, increasing healthcare investments, and rising awareness of cardiovascular diseases all contribute to the demand for these devices. Countries such as China, India, Japan, and Australia are seeing a surge in the adoption of cardiac monitoring technology. The rise in lifestyle diseases such as hypertension and diabetes, combined with the growing use of wearable technologies, is hastening market expansion. As healthcare infrastructure improves and government initiatives promote access to healthcare, the Cardiac Event Monitor market in APAC is expected to expand rapidly.
The cardiac event monitor market is highly competitive, owing to rapid advances in wearable technology, AI-based diagnostics, and rising demand for remote cardiac monitoring. Major players such as GE Healthcare, Progetti Srl, Alivecor, Inc., MeTrax GmbH, and Narang Medical Limited dominate the market with a diverse range of event monitoring solutions such as implantable loop recorders, mobile cardiac telemetry, and wearable patch monitors. Companies such as iRhythm Technologies, BioTelemetry (a Philips subsidiary), and AliveCor are stepping up competition with innovative, patient-friendly devices and real-time data analytics platforms. Strategic mergers, product innovations, and a growing emphasis on home-based cardiac care are influencing market dynamics. North America has a significant market share due to its strong healthcare infrastructure and reimbursement support, whereas Asia-Pacific is experiencing the fastest growth due to rising cardiovascular disease prevalence and increased access to digital health technologies.
In February 2025, Cardiac Biotech Solutions, Inc., a medical technology company, has announced the launch of its next-generation MyCardia AT cardiac event monitor, which is aimed at Southeast Asia, Hong Kong, and Macau. The US FDA-cleared device has a lightweight, user-friendly design and allows for remote cardiac event transmission via iOS, Android, and WeChat apps, improving patient monitoring and convenience.